GlassScriptPhysician profile
Matthew Shane Peterson
NPI 1255319828
$1,258.26
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $99.62 · 2022: $267 · 2024: $224 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $589.76 | 2022-2025 | |
| Galderma Laboratories, L.P. | $216.96 | 2019 | |
| Coopersurgical, INC. | $177.00 | 2019-2020 | |
| Organon LLC | $96.66 | 2024 | |
| Dysis Medical, INC. | $83.33 | 2020 | |
| Mission Pharmacal Company | $28.17 | 2019 | |
| Merck Sharp & Dohme LLC | $19.73 | 2019 | |
| Abbvie INC. | $18.33 | 2019 | |
| Duchesnay USA Incorporated | $15.13 | 2019 | |
| Avion Pharmaceuticals | $13.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.